More than a championship: Edgewood senior Dylan Lenz plays for his brother - WKOW
4 days ago • Google News
LENZ Therapeutics Inc (LENZ)
US$ 35.22998.3%
Price Chart
Key Statistics
Market Cap
$ 741.37M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
192.06K
52W High
$ 38.93
52W Low
$ 14.42
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
24.607
200-Day MA
26.1048
52 Week High
38.93
52 Week Low
14.42
About LENZ
LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
Employees
N/A
Headquarters
Solana Beach, CA
CEO
Mr. Evert B. Schimmelpennink
Latest News
LENZ partners with Lotus to commercialise presbyopia treatment - Pharmaceutical Technology
23 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg